Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
Authors:
- Hannah MillerHMHannah Miller
- Zoltan CziganyZoltan Czigany
- Isabella LurjeILIsabella Lurje
- Sophie ReicheltSRSophie Reichelt
- Jan BednarschJBJan Bednarsch
- Pavel StrnadPavel Strnad
- Christian TrautweinCTChristian Trautwein
- Christoph RoderburgChristoph Roderburg
- Frank TackeFrank Tacke
- Nadine Therese GaisaNGNadine Therese Gaisa
- Ruth Knüchel-ClarkeRKRuth Knüchel-Clarke
- Ulf Peter NeumannUNUlf Peter Neumann
Open Access
Abstract
Tumor angiogenesis plays a pivotal role in hepatocellular carcinoma (HCC) biology. Identifying molecular prognostic markers is critical to further improve treatment selection in these patients. The present study analyzed a subset of 10 germline polymorphisms involved in tumor angiogenesis pathways and their impact on prognosis in HCC patients undergoing partial hepatectomy in a curative intent. Formalin-fixed paraffin-embedded (FFPE) tissues were obtained from 127 HCC patients at a German primary care hospital. Genomic DNA was extracted, and genotyping was carried out using polymerase chain reaction (PCR)–restriction fragment length polymorphism-based protocols. Polymorphisms in interleukin-8 (IL-8) (rs4073; p = 0.047, log-rank test) and vascular endothelial growth factor (VEGF C + 936T) (rs3025039; p = 0.045, log-rank test) were significantly associated with disease-free survival (DFS). After adjusting for covariates in the multivariable model, IL-8 T-251A (rs4073) (adjusted p = 0.010) and a combination of “high-expression” variants of rs4073 and rs3025039 (adjusted p = 0.034) remained significantly associated with DFS. High-expression variants of IL-8 T-251A may serve as an independent molecular marker of prognosis in patients undergoing surgical resection for HCC. Assessment of the patients’ individual genetic risks may help to identify patient subgroups at high risk for recurrence following curative-intent surgery.Keywords
This publication has 63 references indexed in Scilit:
- HCC and angiogenesis: possible targets and future directionsNature Reviews Clinical Oncology, 2011
- Combined effects of IL-8 and CXCR2gene polymorphisms on breast cancer susceptibility and aggressivenessBMC Cancer, 2010
- Single-nucleotide Polymorphisms in the p53 Signaling PathwayCold Spring Harbor Perspectives in Biology, 2009
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumorsMolecular Cancer Therapeutics, 2009
- Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinomaAnnals of Oncology, 2009
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysisBritish Journal of Cancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancerAnnals of Oncology, 2008
- Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectivesJournal of Cancer Research and Clinical Oncology, 2004
- Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10Proceedings of the National Academy of Sciences, 2000